$ILMN anemic earnings outlook sends stock down nearly 5%. #sequencing Fundamental issues?
1 - poor penetration into diagnostics
2- R&D incremental
3- Growth strategy failure (PacBio)pic.twitter.com/al92YjSEG1
U tweetove putem weba ili aplikacija drugih proizvođača možete dodati podatke o lokaciji, kao što su grad ili točna lokacija. Povijest lokacija tweetova uvijek možete izbrisati. Saznajte više
$ILMN anemic earnings outlook sends stock down nearly 5%. #sequencing Fundamental issues?
1 - poor penetration into diagnostics
2- R&D incremental
3- Growth strategy failure (PacBio)pic.twitter.com/al92YjSEG1